PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab
Dirk J Blom,1 Ricardo Dent,2 Rita C Castro,2 Peter P Toth3,4 1Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa; 2Amgen, Inc., Thousand Oaks, CA, 3Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2016-05-01
|
| Series: | Vascular Health and Risk Management |
| Subjects: | |
| Online Access: | https://www.dovepress.com/pcsk9-inhibition-in-the-management-of-hyperlipidemia-focus-on-evolocum-peer-reviewed-article-VHRM |